103rd Day Of Lockdown

Maharashtra2000641080828671 Tamil Nadu107001605921450 Delhi97200682563004 Gujarat35398254141926 Uttar Pradesh2655418154773 Telangana2231211537288 Karnataka215499246335 West Bengal2123114166736 Rajasthan1975615663453 Andhra Pradesh186978422232 Haryana1669012493260 Madhya Pradesh1460411234598 Bihar11860876590 Assam11002674414 Odisha9070622446 Jammu and Kashmir82465143127 Punjab61094306162 Kerala5205304826 Chhatisgarh3161252614 Uttarakhand3093250242 Jharkhand2739203514 Goa16848256 Tripura155812021 Manipur13256670 Himachal Pradesh104871510 Puducherry94644814 Nagaland5782280 Chandigarh4663956 Arunachal Pradesh252751 Mizoram1601230 Sikkim101520 Meghalaya50421
Business Companies 30 Jun 2020 Bharat Biotech&rsquo ...

Bharat Biotech’s COVID-19 vaccine gets nod for human trials

REUTERS
Published Jun 30, 2020, 4:13 pm IST
Updated Jun 30, 2020, 4:13 pm IST
Human trials are scheduled to start across the country in July, developed and manufactured in Bharat Biotech’s facility in Hyderabad
India's first COVID-19 vaccine gets nod for human trials. (AFP Photo)
 India's first COVID-19 vaccine gets nod for human trials. (AFP Photo)

Bharat Biotech’s COVID-19 vaccine has been approved for human trials, making it India’s first domestic candidate to get the green light from the government’s drug regulator as cases surge in a country with more than 1.3 billion people.

The Drug Controller General of India has approved the company’s application to conduct a Phase I and II clinical trial of Covaxin, which was developed along with the Indian Council of Medical Research’s National Institute of Virology, the company said in a statement on Monday.

 

Human clinical trials are scheduled to start across the country in July for the vaccine, which was developed and manufactured in Bharat Biotech’s facility at Genome Valley in Hyderabad, India.

India, which lags only the United States, Brazil and Russia in total cases, reported close to 20,000 new infections on Monday, according to data from the country’s federal Health Ministry.

More than 16,000 people have died from the disease since the first case in India in January — low when compared to countries with similar numbers of cases. But experts fear hospitals in the densely populated nation will be unable to cope with a steep rise in cases.

...




ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT